Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival (Q61868327)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 May 1996

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival

Language	Label	Description	Also known as
English	Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival	scientific article published on 15 May 1996	Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival (English)

0 references

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David Cunningham

3

object named as

David Cunningham

0 references

David Cunningham

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

author name string

Aris Bamias

1

0 references

Mark E. Hill

2

0 references

Andrew R. Norman

4

0 references

Fareeda Y. Ahmed

5

0 references

Andrew Webb

6

0 references

Maggie Watson

7

0 references

Andrea S. Hill

8

0 references

Marianne C. Nicolson

9

0 references

Mary E. O'Brien

10

0 references

T. Christopher Evans

11

0 references

Viola Nicolson

12

0 references

Bamias A

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Hill ME

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Norman AR

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Ahmed FY

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Webb A

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Watson M

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Hill AS

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Nicolson MC

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

O'Brien ME

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Evans TC

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Nicolson V

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

0 references

publication date

15 May 1996

0 references

1 May 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

77

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1978-1985

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Adenocarcinoma of the stomach: are we making progress?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Gastric cancer: chemotherapy of advanced disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

A phase II study of cisplatin in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Chemotherapy of advanced gastric carcinoma: to be completely rewritten?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960515%2977%3A10%3C1978%3A%3AAID-CNCR3%3E3.0.CO%3B2-D

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19960515)77:10<1978::AID-CNCR3>3.0.CO;2-D

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640659%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61868327&oldid=2145835710"